Research study Program year 2020 Source: CMS Open Payments

RSV Ped-002

Research payments

$246,088

98 payments

Through program year 2020, $246,088 in research payments was reported against RSV Ped-002, across 98 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$66,458	27
2019	Research	$179,630	71

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $246,088 98 payments

Who received the money Research payments · program years 2019–2020

Emmaus Research Center INC Organisation paid for research $91,462 28 payments
Sanford Research Center Organisation paid for research $55,969 8 payments
Cotton O'Neil Clinic Organisation paid for research $38,606 28 payments
The Children's Hospital Association Organisation paid for research $37,434 13 payments
University Of Maryland Baltimore Foundation Inc Organisation paid for research $19,599 17 payments
The Research Foundation For The State University Of New York Organisation paid for research $1,332 2 payments
Cotton O'Neil Infusion Center Organisation paid for research $1,080 1 payment
Research Foundation Of Suny Organisation paid for research $608 1 payment

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

7 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.